NAMS
NewAmsterdam Pharma Company N.VWhen NAMS passed all Ten ChecksNewAmsterdam Pharma Company N.V
history · not a forecastOver the past 10 years, NAMS has passed all Ten Checks on 3 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +17.7% in Mar 2023, still rising at session 20.
- May 2026+2.3% -18.0%
- Apr 2026+14.2% -18.0%
- Mar 2023+17.7% -0.6%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about NAMS’s checks
How many technical checks does NAMS pass right now?
As of the Aug 26, 2026 close, NAMS passes 5 of 10 fixed technical checks — the checks not passing: market trend rising, long-term trend rising, holding above short-term average, outperforming the market, adequate stop room.
Why does NAMS fail the "holding above short-term average" check?
NAMS closed at $27.40, 0.3% below its 9-day average ($27.48), so this momentum check fails. It passes again on a close above $27.48.
What price would change NAMS's check count?
The nearest flip level is "holding above short-term average" passes on a close above $27.50. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.